AI-generated summary
The authors describe their Australian experience with 308-nm excimer light therapy, a monochromatic treatment used for focal dermatoses with inflammation or hypopigmentation. The study aims to retrospectively evaluate its different applications in Australian dermatology practice and to provide practical guidance on its use. The abstract does not report specific outcomes or patient numbers.
- Who or what was studied
- Patients with dermatologic conditions treated with excimer light therapy in an Australian setting; exact population not stated in the abstract.
- Wavelengths
- 308 nm
- Limits stated in the abstract
- The abstract does not state the number of patients, the outcomes measured, or the certainty of findings, and the study is described as retrospective.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Inflammation, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.